Aromatase Is the Major Enzyme Metabolizing Buprenorphine in Human Placenta (original) (raw)

The effect of methadone and buprenorphine on human placental aromatase

Mahmoud Ahmed

Biochemical Pharmacology, 2006

View PDFchevron_right

Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry

Allan Barnes, Lauren Jansson, Marilyn Huestis

Analytical and Bioanalytical Chemistry, 2009

View PDFchevron_right

Methadone metabolism by human placenta

Mahmoud Ahmed

Biochemical Pharmacology, 2004

View PDFchevron_right

Transplacental Transfer and Metabolism of Buprenorphine in Preterm Human Placenta

Gary Hankins

American Journal of Perinatology, 2011

View PDFchevron_right

N-Demethylation of levo-α-acetylmethadol by human placental aromatase

Mahmoud Ahmed

Biochemical Pharmacology, 2004

View PDFchevron_right

The effect of opiates on the activity of human placental aromatase/CYP19

Mahmoud Ahmed

Biochemical Pharmacology, 2007

View PDFchevron_right

Maternal Buprenorphine Dose, Placenta Buprenorphine, and Metabolite Concentrations and Neonatal Outcomes

Marilyn Huestis

Therapeutic Drug Monitoring, 2010

View PDFchevron_right

Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women

Marilyn Huestis

Journal of Chromatography B, 2010

View PDFchevron_right

Evidence for a stereospecific [3 H]etorphine binding in human placenta

annick valette

FEBS Letters, 1979

View PDFchevron_right

Bupropion metabolism by human placenta

Gary Hankins

Biochemical Pharmacology, 2010

View PDFchevron_right

Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography–tandem mass spectrometry

Marilyn Huestis

Journal of Chromatography A, 2016

View PDFchevron_right

Urinary Excretion of Buprenorphine, Norbuprenorphine, Buprenorphine-Glucuronide, and Norbuprenorphine-Glucuronide in Pregnant Women Receiving Buprenorphine Maintenance Treatment

Rolley Johnson

Clinical Chemistry, 2009

View PDFchevron_right

Specific binding for opiate-like drugs in the placenta

jean cros

Biochemical Pharmacology, 1980

View PDFchevron_right

Development and validation of a method for the determination of buprenorphine and norbuprenorphine in breast milk by gas chromatography-mass spectrometry

Panagiota Nikolaou

Biomedical Chromatography, 2011

View PDFchevron_right

Simultaneous Quantification of Methadone, Cocaine, Opiates, and Metabolites in Human Placenta by Liquid Chromatography-Mass Spectrometry

Marilyn Huestis

Journal of Analytical Toxicology, 2009

View PDFchevron_right

Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry

Marilyn Huestis

Analytical and Bioanalytical Chemistry, 2011

View PDFchevron_right

The Contribution of Fetal Metabolism to the Disposition of Morphine

Kirsten Abildskov

Drug Metabolism and Disposition, 2004

View PDFchevron_right

Identification of Site of Morphine Action in Pregnant Wistar Rat Placenta Tissue: A C14-Morphine Study

Masoomeh Kazemi

Cell Journal (Yakhteh), 2012

View PDFchevron_right

Bidirectional transfer of methadone across human placenta

Mahmoud Ahmed

Biochemical Pharmacology, 2005

View PDFchevron_right

Transplacental Transfer and Metabolism of Buprenorphine

Sujal Deshmukh

Journal of Pharmacology and Experimental Therapeutics, 2002

View PDFchevron_right

Preliminary Buprenorphine Sublingual Tablet Pharmacokinetic Data in Plasma, Oral Fluid, and Sweat During Treatment of Opioid-Dependent Pregnant Women

Marta Concheiro-Guisan

Therapeutic Drug Monitoring, 2011

View PDFchevron_right

Drug Transfer and Metabolism by the Human Placenta

Jeff A Keelan

Clinical Pharmacokinetics, 2004

View PDFchevron_right